(Q50168618)

English

The incidence of major complications after the performance of extensive upper abdominal surgical procedures during primary cytoreduction of advanced ovarian, tubal, and peritoneal carcinomas.

scientific article published on 6 July 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 February 2018

http://europepmc.org/abstract/MED/20609464

The incidence of major complications after the performance of extensive upper abdominal surgical procedures during primary cytoreduction of advanced ovarian, tubal, and peritoneal carcinomas. (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 February 2018

http://europepmc.org/abstract/MED/20609464

object named as

Valentin Kolev

4

0 references

object named as

Jae Huh

5

0 references

1

object named as

Dennis S Chi

1 reference

Europe PubMed Central

PubMed publication ID

26 February 2018

http://europepmc.org/abstract/MED/20609464

Richard R Barakat

13

object named as

Richard R Barakat

1 reference

Europe PubMed Central

PubMed publication ID

26 February 2018

http://europepmc.org/abstract/MED/20609464

10

object named as

Yukio Sonoda

1 reference

Europe PubMed Central

PubMed publication ID

26 February 2018

http://europepmc.org/abstract/MED/20609464

Nadeem R. Abu-Rustum

11

object named as

Nadeem R Abu-Rustum

1 reference

Europe PubMed Central

PubMed publication ID

26 February 2018

http://europepmc.org/abstract/MED/20609464

Ginger J. Gardner

7

object named as

Ginger J Gardner

1 reference

Europe PubMed Central

PubMed publication ID

26 February 2018

http://europepmc.org/abstract/MED/20609464

Oliver Zivanovic

2

object named as

Oliver Zivanovic

1 reference

Europe PubMed Central

PubMed publication ID

26 February 2018

http://europepmc.org/abstract/MED/20609464

Douglas A Levine

9

object named as

Douglas A Levine

1 reference

Europe PubMed Central

PubMed publication ID

26 February 2018

http://europepmc.org/abstract/MED/20609464

Kimberly L Levinson

3

object named as

Kimberly L Levinson

1 reference

Europe PubMed Central

PubMed publication ID

26 February 2018

http://europepmc.org/abstract/MED/20609464

12

object named as

Carol L Brown

1 reference

Europe PubMed Central

PubMed publication ID

26 February 2018

http://europepmc.org/abstract/MED/20609464

author name string

Joseph Dottino

6

1 reference

Europe PubMed Central

PubMed publication ID

26 February 2018

http://europepmc.org/abstract/MED/20609464

Mario M Leitao

8

1 reference

Europe PubMed Central

PubMed publication ID

26 February 2018

http://europepmc.org/abstract/MED/20609464

language of work or name

0 references

publication date

6 July 2010

1 reference

Europe PubMed Central

PubMed publication ID

26 February 2018

http://europepmc.org/abstract/MED/20609464

Gynecologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

26 February 2018

http://europepmc.org/abstract/MED/20609464

119

1 reference

Europe PubMed Central

PubMed publication ID

26 February 2018

http://europepmc.org/abstract/MED/20609464

1

1 reference

Europe PubMed Central

PubMed publication ID

26 February 2018

http://europepmc.org/abstract/MED/20609464

38-42

1 reference

Europe PubMed Central

PubMed publication ID

26 February 2018

http://europepmc.org/abstract/MED/20609464

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.05.031

7 January 2021

Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.05.031

7 January 2021

Intraperitoneal cisplatin and paclitaxel in ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.05.031

7 January 2021

Identification of prognostic factors in advanced epithelial ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.05.031

7 January 2021

Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.05.031

7 January 2021

What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.05.031

7 January 2021

Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.05.031

7 January 2021

Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.05.031

7 January 2021

Aggressive surgical effort and improved survival in advanced-stage ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.05.031

7 January 2021

Prognostic factors in advanced ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.05.031

7 January 2021

Stage IV ovarian cancer: impact of surgical debulking

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.05.031

7 January 2021

Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.05.031

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.05.031

7 January 2021

The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC–IV epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.05.031

7 January 2021

Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.05.031

7 January 2021

What are the current surgical objectives, strategies, and technical capabilities of gynecologic oncologists treating advanced epithelial ovarian cancer?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.05.031

7 January 2021

Assessment of outcomes and morbidity following diaphragmatic peritonectomy for women with ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.05.031

7 January 2021

Incidence and management of pleural effusions after diaphragm peritonectomy or resection for advanced mullerian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.05.031

7 January 2021

Splenectomy as part of cytoreductive surgery in ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.05.031

7 January 2021

Splenectomy in the context of primary cytoreductive operations for advanced epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.05.031

7 January 2021

Incidence and management of pancreatic leaks after splenectomy with distal pancreatectomy performed during primary cytoreductive surgery for advanced ovarian, peritoneal and fallopian tube cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.05.031

7 January 2021

Transfusion utilization during adnexal or peritoneal cancer surgery: effects on symptomatic venous thromboembolism and survival

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.05.031

7 January 2021

Effect of perioperative venous thromboembolism on survival in ovarian, primary peritoneal, and fallopian tube cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.05.031

7 January 2021

Postoperative mortality after primary cytoreductive surgery for advanced stage epithelial ovarian cancer: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.05.031

7 January 2021

Identifiers

10.1016/J.YGYNO.2010.05.031

1 reference

Europe PubMed Central

PubMed publication ID

26 February 2018

http://europepmc.org/abstract/MED/20609464

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 February 2018

http://europepmc.org/abstract/MED/20609464

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50168618&oldid=2046349721"